962 related articles for article (PubMed ID: 25988463)
1. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
Ossenkoppele R; Jansen WJ; Rabinovici GD; Knol DL; van der Flier WM; van Berckel BN; Scheltens P; Visser PJ; ; Verfaillie SC; Zwan MD; Adriaanse SM; Lammertsma AA; Barkhof F; Jagust WJ; Miller BL; Rosen HJ; Landau SM; Villemagne VL; Rowe CC; Lee DY; Na DL; Seo SW; Sarazin M; Roe CM; Sabri O; Barthel H; Koglin N; Hodges J; Leyton CE; Vandenberghe R; van Laere K; Drzezga A; Forster S; Grimmer T; Sánchez-Juan P; Carril JM; Mok V; Camus V; Klunk WE; Cohen AD; Meyer PT; Hellwig S; Newberg A; Frederiksen KS; Fleisher AS; Mintun MA; Wolk DA; Nordberg A; Rinne JO; Chételat G; Lleo A; Blesa R; Fortea J; Madsen K; Rodrigue KM; Brooks DJ
JAMA; 2015 May; 313(19):1939-49. PubMed ID: 25988463
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
Jansen WJ; Ossenkoppele R; Knol DL; Tijms BM; Scheltens P; Verhey FR; Visser PJ; ; Aalten P; Aarsland D; Alcolea D; Alexander M; Almdahl IS; Arnold SE; Baldeiras I; Barthel H; van Berckel BN; Bibeau K; Blennow K; Brooks DJ; van Buchem MA; Camus V; Cavedo E; Chen K; Chetelat G; Cohen AD; Drzezga A; Engelborghs S; Fagan AM; Fladby T; Fleisher AS; van der Flier WM; Ford L; Förster S; Fortea J; Foskett N; Frederiksen KS; Freund-Levi Y; Frisoni GB; Froelich L; Gabryelewicz T; Gill KD; Gkatzima O; Gómez-Tortosa E; Gordon MF; Grimmer T; Hampel H; Hausner L; Hellwig S; Herukka SK; Hildebrandt H; Ishihara L; Ivanoiu A; Jagust WJ; Johannsen P; Kandimalla R; Kapaki E; Klimkowicz-Mrowiec A; Klunk WE; Köhler S; Koglin N; Kornhuber J; Kramberger MG; Van Laere K; Landau SM; Lee DY; de Leon M; Lisetti V; Lleó A; Madsen K; Maier W; Marcusson J; Mattsson N; de Mendonça A; Meulenbroek O; Meyer PT; Mintun MA; Mok V; Molinuevo JL; Møllergård HM; Morris JC; Mroczko B; Van der Mussele S; Na DL; Newberg A; Nordberg A; Nordlund A; Novak GP; Paraskevas GP; Parnetti L; Perera G; Peters O; Popp J; Prabhakar S; Rabinovici GD; Ramakers IH; Rami L; Resende de Oliveira C; Rinne JO; Rodrigue KM; Rodríguez-Rodríguez E; Roe CM; Rot U; Rowe CC; Rüther E; Sabri O; Sanchez-Juan P; Santana I; Sarazin M; Schröder J; Schütte C; Seo SW; Soetewey F; Soininen H; Spiru L; Struyfs H; Teunissen CE; Tsolaki M; Vandenberghe R; Verbeek MM; Villemagne VL; Vos SJ; van Waalwijk van Doorn LJ; Waldemar G; Wallin A; Wallin ÅK; Wiltfang J; Wolk DA; Zboch M; Zetterberg H
JAMA; 2015 May; 313(19):1924-38. PubMed ID: 25988462
[TBL] [Abstract][Full Text] [Related]
3. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.
Insel PS; Hansson O; Mattsson-Carlgren N
JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487
[TBL] [Abstract][Full Text] [Related]
4. Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span.
Jack CR; Wiste HJ; Weigand SD; Knopman DS; Vemuri P; Mielke MM; Lowe V; Senjem ML; Gunter JL; Machulda MM; Gregg BE; Pankratz VS; Rocca WA; Petersen RC
JAMA Neurol; 2015 May; 72(5):511-9. PubMed ID: 25775353
[TBL] [Abstract][Full Text] [Related]
5. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
[TBL] [Abstract][Full Text] [Related]
6. ApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid Levels.
Steward A; Biel D; Dewenter A; Roemer S; Wagner F; Dehsarvi A; Rathore S; Otero Svaldi D; Higgins I; Brendel M; Dichgans M; Shcherbinin S; Ewers M; Franzmeier N
JAMA Neurol; 2023 Dec; 80(12):1295-1306. PubMed ID: 37930695
[TBL] [Abstract][Full Text] [Related]
7. Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease.
Lim YY; Kalinowski P; Pietrzak RH; Laws SM; Burnham SC; Ames D; Villemagne VL; Fowler CJ; Rainey-Smith SR; Martins RN; Rowe CC; Masters CL; Maruff PT
JAMA Neurol; 2018 Apr; 75(4):488-494. PubMed ID: 29356823
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
9. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
[TBL] [Abstract][Full Text] [Related]
10. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
Smith R; Strandberg O; Mattsson-Carlgren N; Leuzy A; Palmqvist S; Pontecorvo MJ; Devous MD; Ossenkoppele R; Hansson O
Brain; 2020 Dec; 143(12):3805-3815. PubMed ID: 33439987
[TBL] [Abstract][Full Text] [Related]
11. Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex,
Therriault J; Pascoal TA; Benedet AL; Tissot C; Savard M; Chamoun M; Lussier F; Kang MS; Berzgin G; Wang T; Fernandes-Arias J; Massarweh G; Soucy JP; Vitali P; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P
Neurology; 2021 Feb; 96(7):e975-e985. PubMed ID: 33443136
[TBL] [Abstract][Full Text] [Related]
12. Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype.
Nadkarni NK; Perera S; Snitz BE; Mathis CA; Price J; Williamson JD; DeKosky ST; Klunk WE; Lopez OL
JAMA Neurol; 2017 Jan; 74(1):82-90. PubMed ID: 27842173
[TBL] [Abstract][Full Text] [Related]
13. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.
Jansen WJ; Janssen O; Tijms BM; Vos SJB; Ossenkoppele R; Visser PJ; ; Aarsland D; Alcolea D; Altomare D; von Arnim C; Baiardi S; Baldeiras I; Barthel H; Bateman RJ; Van Berckel B; Binette AP; Blennow K; Boada M; Boecker H; Bottlaender M; den Braber A; Brooks DJ; Van Buchem MA; Camus V; Carill JM; Cerman J; Chen K; Chételat G; Chipi E; Cohen AD; Daniels A; Delarue M; Didic M; Drzezga A; Dubois B; Eckerström M; Ekblad LL; Engelborghs S; Epelbaum S; Fagan AM; Fan Y; Fladby T; Fleisher AS; Van der Flier WM; Förster S; Fortea J; Frederiksen KS; Freund-Levi Y; Frings L; Frisoni GB; Fröhlich L; Gabryelewicz T; Gertz HJ; Gill KD; Gkatzima O; Gómez-Tortosa E; Grimmer T; Guedj E; Habeck CG; Hampel H; Handels R; Hansson O; Hausner L; Hellwig S; Heneka MT; Herukka SK; Hildebrandt H; Hodges J; Hort J; Huang CC; Iriondo AJ; Itoh Y; Ivanoiu A; Jagust WJ; Jessen F; Johannsen P; Johnson KA; Kandimalla R; Kapaki EN; Kern S; Kilander L; Klimkowicz-Mrowiec A; Klunk WE; Koglin N; Kornhuber J; Kramberger MG; Kuo HC; Van Laere K; Landau SM; Landeau B; Lee DY; de Leon M; Leyton CE; Lin KJ; Lleó A; Löwenmark M; Madsen K; Maier W; Marcusson J; Marquié M; Martinez-Lage P; Maserejian N; Mattsson N; de Mendonça A; Meyer PT; Miller BL; Minatani S; Mintun MA; Mok VCT; Molinuevo JL; Morbelli SD; Morris JC; Mroczko B; Na DL; Newberg A; Nobili F; Nordberg A; Olde Rikkert MGM; de Oliveira CR; Olivieri P; Orellana A; Paraskevas G; Parchi P; Pardini M; Parnetti L; Peters O; Poirier J; Popp J; Prabhakar S; Rabinovici GD; Ramakers IH; Rami L; Reiman EM; Rinne JO; Rodrigue KM; Rodríguez-Rodriguez E; Roe CM; Rosa-Neto P; Rosen HJ; Rot U; Rowe CC; Rüther E; Ruiz A; Sabri O; Sakhardande J; Sánchez-Juan P; Sando SB; Santana I; Sarazin M; Scheltens P; Schröder J; Selnes P; Seo SW; Silva D; Skoog I; Snyder PJ; Soininen H; Sollberger M; Sperling RA; Spiru L; Stern Y; Stomrud E; Takeda A; Teichmann M; Teunissen CE; Thompson LI; Tomassen J; Tsolaki M; Vandenberghe R; Verbeek MM; Verhey FRJ; Villemagne V; Villeneuve S; Vogelgsang J; Waldemar G; Wallin A; Wallin ÅK; Wiltfang J; Wolk DA; Yen TC; Zboch M; Zetterberg H
JAMA Neurol; 2022 Mar; 79(3):228-243. PubMed ID: 35099509
[TBL] [Abstract][Full Text] [Related]
14.
Palta P; Rippon B; Reitz C; He H; Sherwood G; Ceballos F; Teresi J; Razlighi Q; Moreno H; Brickman AM; Luchsinger JA
Neurology; 2020 Oct; 95(15):e2086-e2094. PubMed ID: 32847955
[TBL] [Abstract][Full Text] [Related]
15. Effect of APOE ε4 genotype on amyloid-β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment.
Li W; Li R; Yan S; Zhao Z; Shan Y; Qi Z; Lu J;
Eur J Neurol; 2023 Mar; 30(3):587-596. PubMed ID: 36448771
[TBL] [Abstract][Full Text] [Related]
16. Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia.
Salvadó G; Grothe MJ; Groot C; Moscoso A; Schöll M; Gispert JD; Ossenkoppele R;
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2212-2224. PubMed ID: 33521872
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia.
Bergeron D; Gorno-Tempini ML; Rabinovici GD; Santos-Santos MA; Seeley W; Miller BL; Pijnenburg Y; Keulen MA; Groot C; van Berckel BNM; van der Flier WM; Scheltens P; Rohrer JD; Warren JD; Schott JM; Fox NC; Sanchez-Valle R; Grau-Rivera O; Gelpi E; Seelaar H; Papma JM; van Swieten JC; Hodges JR; Leyton CE; Piguet O; Rogalski EJ; Mesulam MM; Koric L; Kristensen N; Pariente J; Dickerson B; Mackenzie IR; Hsiung GR; Belliard S; Irwin DJ; Wolk DA; Grossman M; Jones M; Harris J; Mann D; Snowden JS; Chrem-Mendez P; Calandri IL; Amengual AA; Miguet-Alfonsi C; Magnin E; Magnani G; Santangelo R; Deramecourt V; Pasquier F; Mattsson N; Nilsson C; Hansson O; Keith J; Masellis M; Black SE; Matías-Guiu JA; Cabrera-Martin MN; Paquet C; Dumurgier J; Teichmann M; Sarazin M; Bottlaender M; Dubois B; Rowe CC; Villemagne VL; Vandenberghe R; Granadillo E; Teng E; Mendez M; Meyer PT; Frings L; Lleó A; Blesa R; Fortea J; Seo SW; Diehl-Schmid J; Grimmer T; Frederiksen KS; Sánchez-Juan P; Chételat G; Jansen W; Bouchard RW; Laforce RJ; Visser PJ; Ossenkoppele R
Ann Neurol; 2018 Nov; 84(5):729-740. PubMed ID: 30255971
[TBL] [Abstract][Full Text] [Related]
18. Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
Langbaum JB; Chen K; Caselli RJ; Lee W; Reschke C; Bandy D; Alexander GE; Burns CM; Kaszniak AW; Reeder SA; Corneveaux JJ; Allen AN; Pruzin J; Huentelman MJ; Fleisher AS; Reiman EM
Arch Neurol; 2010 Apr; 67(4):462-8. PubMed ID: 20385913
[TBL] [Abstract][Full Text] [Related]
19. Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down Syndrome.
D'Souza H; Mason L; Mok KY; Startin CM; Hamburg S; Hithersay R; Baksh RA; Hardy J; Strydom A; Thomas MSC;
JAMA Netw Open; 2020 Sep; 3(9):e2018221. PubMed ID: 32986108
[TBL] [Abstract][Full Text] [Related]
20. Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly.
Yi D; Lee DY; Sohn BK; Choe YM; Seo EH; Byun MS; Woo JI
Am J Geriatr Psychiatry; 2014 Oct; 22(10):961-70. PubMed ID: 24495404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
